Clonality Assessment of Cutaneous B-Cell Lymphoid Proliferations
Authors:
- Kristian T. SchafernakKSKristian T. Schafernak
- Daina VariakojisDVDaina Variakojis
- Charles L. GoolsbyCGCharles L. Goolsby
- Raelynn M. TuckerRTRaelynn M. Tucker
- María E. Martínez-EscalaMMMaría E. Martínez-Escala
- Frederick A. SmithFSFrederick A. Smith
- David DittmanDDDavid Dittman
- Anjen ChennACAnjen Chenn
- Joan GuitartJGJoan Guitart
- 1 October 2014
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 36 (10) , 781-795
Abstract
Cutaneous lymphoid infiltrates are diagnostically challenging. Although ancillary techniques to assess clonality can help distinguish between reactive lymphoid hyperplasia and lymphoma, one of the most widely used techniques in hematopathology, flow cytometry immunophenotyping (FCI), has not been routinely applied to skin specimens. We performed FCI on 73 skin specimens from 67 patients clinically suspected of having a cutaneous B-cell lymphoma (CBCL) and compared the results with those obtained from immunoglobulin heavy chain (IGH) gene molecular studies (58 cases, primarily by polymerase chain reaction) and either immunohistochemistry (IHC) or in situ hybridization to evaluate for light chain restriction (22 and 2 cases, respectively). Sufficient quantity of CD45 (leukocyte common antigen)-positive cells and staining quality were achieved in 88% of cases by FCI, and clonality was detected in 68% of CBCLs versus molecular studies showing sufficient DNA quality in 74% and only 39% clonality detection, and interpretable/contributory IHC results in 84% of cases with 55% clonality detection. Clonality was documented more frequently in secondary rather than primary CBCLs by all 3 techniques. Therefore, FCI is feasible and appears to be more reliable than molecular studies or IHC/in situ hybridization for detecting clonality in CBCLs and can provide additional prognostically and therapeutically relevant information. The exception is cases with plasmacytic differentiation such as marginal zone lymphoma for which IHC might be a superior tool. We have also shown that a large subset of primary cutaneous follicle center lymphomas express CD10 and/or BCL2 by FCI. Recent advances in FCI beg the question of applicability to cutaneous T-cell and NK-cell lymphomas.Keywords
This publication has 44 references indexed in Scilit:
- A Single Tube, Four-Color Flow Cytometry Assay for Evaluation of ZAP-70 and CD38 Expression in Chronic Lymphocytic LeukemiaAmerican Journal of Clinical Pathology, 2010
- Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vβ chain antibodies and its application in blood stagingLaboratory Investigation, 2010
- Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survivalBlood, 2009
- Malleable Immunoglobulin Genes and Hematopathology – The Good, the Bad, and the Ugly: A Paper from the 2007 William Beaumont Hospital Symposium on Molecular PathologyThe Journal of Molecular Diagnostics, 2008
- Pulmonary Langerhans Cell HistiocytosisClinical Pulmonary Medicine, 2007
- Unusual presentation of B-cell lymphoma as a cutaneous abscessJournal of the American Academy of Dermatology, 2006
- A Comparison of Morphologic Features, Flow Cytometry, TCR-VβAnalysis, and TCR-PCR in Qualitative and Quantitative Assessment of Peripheral Blood Involvement by Sézary SyndromeAmerican Journal of Clinical Pathology, 2006
- New aspects in the biology of cutaneous B‐cell lymphomasJournal of Cutaneous Pathology, 2006
- Prominent Clonal B-Cell Populations Identified by Flow Cytometry in Histologically Reactive Lymphoid ProliferationsAmerican Journal of Clinical Pathology, 2004
- Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometryCytometry, 1991